ClinVar Genomic variation as it relates to human health
NM_000235.4(LIPA):c.260G>T (p.Gly87Val)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000235.4(LIPA):c.260G>T (p.Gly87Val)
Variation ID: 88770 Accession: VCV000088770.19
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q23.31 10: 89228368 (GRCh38) [ NCBI UCSC ] 10: 90988125 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Sep 16, 2016 Jun 17, 2024 Mar 17, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000235.4:c.260G>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000226.2:p.Gly87Val missense NM_001127605.3:c.260G>T NP_001121077.1:p.Gly87Val missense NM_001288979.2:c.-89G>T 5 prime UTR NC_000010.11:g.89228368C>A NC_000010.10:g.90988125C>A NG_008194.1:g.28536G>T - Protein change
- G87V
- Other names
- -
- Canonical SPDI
- NC_000010.11:89228367:C:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00001
The Genome Aggregation Database (gnomAD), exomes 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
LIPA | - | - |
GRCh38 GRCh37 |
654 | 686 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
May 8, 2023 | RCV000191997.21 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
May 18, 2022 | RCV001269917.11 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jan 13, 2024 | RCV001376576.13 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Mar 17, 2024 | RCV003987346.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Jan 19, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Cholesteryl ester storage disease
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000797291.1
First in ClinVar: Mar 16, 2017 Last updated: Mar 16, 2017 |
|
|
Pathogenic
(May 19, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics and Genomics, Karolinska University Hospital
Accession: SCV001450275.1
First in ClinVar: Dec 12, 2020 Last updated: Dec 12, 2020 |
Number of individuals with the variant: 5
|
|
Pathogenic
(May 18, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002756618.1
First in ClinVar: Dec 03, 2022 Last updated: Dec 03, 2022 |
Comment:
Published functional studies demonstrate a damaging effect due to significantly reduced enzyme activity compared to wildtype (Pagani et al., 1998; Zschenker et al., 2001; Vinje … (more)
Published functional studies demonstrate a damaging effect due to significantly reduced enzyme activity compared to wildtype (Pagani et al., 1998; Zschenker et al., 2001; Vinje et al., 2018; Vinje et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26225414, 23424026, 11441129, 28374935, 31589614, 8894696, 31131398, 22138108, 30684275, 9684740, 33857477, 29196158, 21291321) (less)
|
|
Pathogenic
(Feb 01, 2024)
|
criteria provided, single submitter
Method: curation
|
Cholesteryl ester storage disease
Affected status: no
Allele origin:
germline
|
Laboratory of Medical Genetics, National & Kapodistrian University of Athens
Accession: SCV005051851.1
First in ClinVar: Jun 17, 2024 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Dec 30, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Cholesteryl ester storage disease
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002810889.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(May 08, 2023)
|
criteria provided, single submitter
Method: research
|
Cholesteryl ester storage disease
Affected status: yes
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV003924300.1
First in ClinVar: May 20, 2023 Last updated: May 20, 2023 |
|
|
Pathogenic
(Jan 13, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Wolman disease
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000831923.6
First in ClinVar: Oct 10, 2018 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 87 of the LIPA protein (p.Gly87Val). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 87 of the LIPA protein (p.Gly87Val). This variant is present in population databases (rs587778878, gnomAD 0.003%). This missense change has been observed in individuals with cholesteryl ester storage disease (CESD) or Wolman disease (PMID: 2129132, 8894696, 11441129, 23424026, 28374935). ClinVar contains an entry for this variant (Variation ID: 88770). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LIPA protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects LIPA function (PMID: 9684740, 11441129). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 17, 2024)
|
criteria provided, single submitter
Method: research
|
Cholesteryl ester storage disease
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004804781.2
First in ClinVar: Mar 30, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
Wolman disease
Affected status: unknown
Allele origin:
germline
|
FirmaLab, FirmaLab
Accession: SCV000106039.1
First in ClinVar: Mar 16, 2017 Last updated: Mar 16, 2017 |
|
|
Pathogenic
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Lysosomal acid lipase deficiency
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001453550.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Lysosomal acid lipase deficiency
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000246263.3
First in ClinVar: Oct 05, 2015 Last updated: Oct 01, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Prenatal sonographic findings in a case of Wolman's disease. | Blitz MJ | Journal of clinical ultrasound : JCU | 2018 | PMID: 28374935 |
Lysosomal Acid Lipase Deficiency. | Adam MP | - | 2016 | PMID: 26225414 |
Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications. | Yanir A | Molecular genetics and metabolism | 2013 | PMID: 23583223 |
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. | Scott SA | Hepatology (Baltimore, Md.) | 2013 | PMID: 23424026 |
Wolman disease (LIPA p.G87V) genotype frequency in people of Iranian-Jewish ancestry. | Valles-Ayoub Y | Genetic testing and molecular biomarkers | 2011 | PMID: 21291321 |
Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. | Zschenker O | Journal of lipid research | 2001 | PMID: 11441129 |
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. | Pagani F | Journal of lipid research | 1998 | PMID: 9684740 |
Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. | Pagani F | Human molecular genetics | 1996 | PMID: 8894696 |
Permeability of gentamicin and polymyxin B into the inside of Bacillus subtilis spores. | Fujita Y | Microbiology and immunology | 1990 | PMID: 2129132 |
Text-mined citations for rs587778878 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.